Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Stanke-Labesque

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|June 14, 2000
Human internal mammary artery contraction by isoprostaglandin f(2alpha) type-III [8-iso-prostaglandin F(2alpha)]J L Cracowski, F Stanke-Labesque, P Devillier, et al.
Journal of Cardiovascular Pharmacology|April 25, 2000
Furosemide inhibits thromboxane A2-induced contraction in isolated human internal mammary artery and saphenous veinF Stanke-Labesque, J L Cracowski, P Bedouch, et al.
Journal of Cardiovascular Pharmacology|May 17, 2000
Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veinsB Gardan, J L Cracowski, C Sessa, et al.
Life Sciences|May 15, 2001
Isoprostaglandin E2 type-III (8-iso-prostaglandin E2) evoked contractions in the human internal mammary arteryJ L Cracowski, P Devillier, O Chavanon, et al.
Journal of Cardiovascular Pharmacology|November 5, 1999
Vasorelaxant actions of enoximone, dobutamine, and the combination on human arterial coronary bypass graftsJ L Cracowski, F Stanke-Labesque, O Chavanon, et al.
Arthritis and Rheumatism|May 16, 2001
Enhanced in vivo lipid peroxidation in scleroderma spectrum disordersJ L Cracowski, C Marpeau, P H Carpentier, et al.
Clinical Transplantation|February 13, 2001
Urinary F2-isoprostanes formation in kidney transplantationJ L Cracowski, C Souvignet, N Quirin, et al.
Gastroenterologie Clinique Et Biologique|June 2, 2009
Optimizing ribavirin dosage: a new challenge to improve treatment efficacy in genotype 1 hepatitis C patientsV Loustaud-Ratti, F Stanke-Labesque, P Marquet, et al.
European Journal of Pharmacology|January 29, 2000
Thromboxane A(2) modulates cyclic AMP relaxation and production in human internal mammary arteryJ L Cracowski, F Stanke-Labesque, O Chavanon, et al.
Heart (British Cardiac Society)|September 20, 2000
Increased formation of F(2)-isoprostanes in patients with severe heart failureJ L Cracowski, F Tremel, C Marpeau, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|June 14, 2000
Human internal mammary artery contraction by isoprostaglandin f(2alpha) type-III [8-iso-prostaglandin F(2alpha)]J L Cracowski, F Stanke-Labesque, P Devillier, et al.
Journal of Cardiovascular Pharmacology|April 25, 2000
Furosemide inhibits thromboxane A2-induced contraction in isolated human internal mammary artery and saphenous veinF Stanke-Labesque, J L Cracowski, P Bedouch, et al.
Journal of Cardiovascular Pharmacology|May 17, 2000
Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veinsB Gardan, J L Cracowski, C Sessa, et al.
Life Sciences|May 15, 2001
Isoprostaglandin E2 type-III (8-iso-prostaglandin E2) evoked contractions in the human internal mammary arteryJ L Cracowski, P Devillier, O Chavanon, et al.
Journal of Cardiovascular Pharmacology|November 5, 1999
Vasorelaxant actions of enoximone, dobutamine, and the combination on human arterial coronary bypass graftsJ L Cracowski, F Stanke-Labesque, O Chavanon, et al.
Arthritis and Rheumatism|May 16, 2001
Enhanced in vivo lipid peroxidation in scleroderma spectrum disordersJ L Cracowski, C Marpeau, P H Carpentier, et al.
Clinical Transplantation|February 13, 2001
Urinary F2-isoprostanes formation in kidney transplantationJ L Cracowski, C Souvignet, N Quirin, et al.
Gastroenterologie Clinique Et Biologique|June 2, 2009
Optimizing ribavirin dosage: a new challenge to improve treatment efficacy in genotype 1 hepatitis C patientsV Loustaud-Ratti, F Stanke-Labesque, P Marquet, et al.
European Journal of Pharmacology|January 29, 2000
Thromboxane A(2) modulates cyclic AMP relaxation and production in human internal mammary arteryJ L Cracowski, F Stanke-Labesque, O Chavanon, et al.
Heart (British Cardiac Society)|September 20, 2000
Increased formation of F(2)-isoprostanes in patients with severe heart failureJ L Cracowski, F Tremel, C Marpeau, et al.
Pageof 4